Perspectives of Industry

11:00-11:50

Earl Lewis Room

Perspectives of the Industry feature respectful leaders and key players in the pharmacy industry who take on diverse and vital roles, with experience working in Pfizer, Blue Cross Blue Shield, and in pharmaceutical law . You will have the opportunity to explore in depth what kind of path you can pursue in the Industry.

Panelists

Dr. Kim Moon

Kim Moon is the Medication Therapy Management program manager in the Senior Health Services Medicare Pharmacy Department, a division of Blue Cross Blue Shield of Michigan.
She has been a pharmacist with BCBSM/SHS since 2012 and has been heavily involved in Part D Star ratings quality improvement. Kim is the Residency Program Director for the PGY1 SHS Medicare Managed Care Pharmacy Residency, and she also precepts fourth-year pharmacy students and lectures at the pharmacy schools of both Wayne State University and the University of Michigan.
She has a Doctor of Pharmacy degree from Wayne State University and a Bachelor of Science degree in Medical Technology from Michigan State University.

Dr. Dave Barnes

Dave graduated with a degree in pharmacy from The School of Pharmacy, U. of London (“The Square”). After completing a year’s pharmacy internship, he returned to The School of Pharmacy to undertake a Ph.D. in Pharmaceutical Sciences.
Dave then joined Pfizer’s R&D division in Sandwich, England and for the next 13 years worked on developing drug products of locally discovered molecules, from early pre-formulation through scale-up and transfer into production sites in Europe and the US.
In 2001, with the acquisition of Parke-Davis, Dave moved to Ann Arbor to complete the construction and commissioning of the new Pharmaceutical Sciences building (550/TDF). Upon the successful start-up of the facility, he moved to the Clinical Trial Materials department managing activities across the Ann Arbor, Kalamazoo and Groton, CT sites.
In 2008, with the closure of the Ann Arbor facility, Dave teamed up with Gerry Cox to set up Velesco Pharmaceutical Services which provides formulation and analytical development services for small to medium sized pharma companies as well as the provision of small scale, non-sterile cGMP supplies for early stage clinical studies.
Velesco now has 20 colleagues with laboratory and manufacturing facilities in Wixom MI as well as a business development office in the Boston area.

Dr. Kevin Townsend

Kevin Townsend, PharmD, MSc, BCPS is Senior Director and Executive Medical Lead for the Pfizer US Enterprise Strategic Alliance Team. He received a Doctor of Pharmacy from the University of Michigan College of Pharmacy and a Master of Science in Clinical Research Design and Statistical Analysis from the University of Michigan School of Public Health. Following a pharmacy residency at Duke University Medical Center, he was Clinical Pharmacist at the University of Michigan Health System and Clinical Associate Professor of Pharmacy at the College of Pharmacy before joining Pfizer Medical Affairs.
Kevin’s career at Pfizer has focused on collaborations with leading health systems in the areas of outcomes research, quality improvement, pharmacoeconomics, health innovation, and education. Dr. Townsend maintains an adjunct appointment at the University of Michigan College of Pharmacy and is a board-certified pharmacotherapy specialist. He has published numerous manuscripts and abstracts in the areas of medication adherence, dyslipidemia, hypertension, anticoagulation, diabetes, drug interactions, NASH, and others.
In the community, Dr. Townsend founded a 501(c)3 organization focused on connecting low-income patients with medication assistance programs. He is also a board member and coach for Ann Arbor Gold Fastpitch and volunteers for Special Olympics of Michigan.